Area9 Lyceum Blog

Innovations in pharmaceutical and medical technology—gene therapies, stem-cell treatments, and other cutting-edge therapeutic approaches—demand intensive training, both inside and outside the company. Adaptive learning offers a proven approach.

A focus on quick fixes results in learning and development (L&D) “technical debt” that is too great for companies to bear today, given greater demands to build proficiencies throughout their workforce. By understanding what cutting-edge adaptive learning looks like, companies can take the first step toward paying down technical debt and improving L&D with a truly personalized approach.

To level the playing field of future job opportunities, all workers must be reskilled to meet the ever-increasing demands of the technology-enabled workplace. This requires the “rulebook” for learning to be rewritten, no longer assuming a distribution curve in performance, but rather seeing everyone as capable of achieving proficiency and mastery, provided they are given the targeted support and time they need.

New talent development approaches are driving the thinking around hiring vs. retraining to respond to rapidly evolving technology, a global skills shortage, and the cost of continuously hiring new talent. As employers grapple with their talent demands, a conversation around reskilling must occur among managers, corporate leaders, HR, and chief learning officers (CLOs).